{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:30:16Z","timestamp":1793313016570,"version":"4.5.0"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH R01","award":["NS092754"],"award-info":[{"award-number":["NS092754"]}]},{"name":"State of New York Spinal Cord Injury Research Program Institutional Grant","award":["C32245GG"],"award-info":[{"award-number":["C32245GG"]}]},{"name":"New York Spinal Cord Injury Research Board Predoctoral Fellowship Award","award":["C30606GG"],"award-info":[{"award-number":["C30606GG"]}]},{"name":"National Science Foundation Graduate Research Fellowship Program","award":["DGE-1744655"],"award-info":[{"award-number":["DGE-1744655"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.brainresbull.2019.05.024","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T22:16:36Z","timestamp":1559686596000},"page":"216-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors"],"prefix":"10.1016","volume":"150","author":[{"given":"Devan L.","family":"Puhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2019.05.024_bib0005","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1089\/hum.1996.7.16-1947","article-title":"A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine","volume":"7","author":"Abdallah","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuroscience.2016.10.026","article-title":"Non-viral xylosyltransferase-1 siRNA delivery as an effective alternative to chondroitinase in an in vitro model of reactive astrocytes","volume":"339","author":"Abu-Rub","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0015","doi-asserted-by":"crossref","first-page":"17247","DOI":"10.1073\/pnas.1305000110","article-title":"Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms","volume":"110","author":"Agarwal","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ppul.24203","article-title":"Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy","volume":"54","author":"Al\u2010Zaidy","year":"2019","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0025","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1002\/smll.201501167","article-title":"Peptide-like polymers exerting effective glioma-targeted siRNA delivery and release for therapeutic application","volume":"11","author":"An","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/10430340360535751","article-title":"Stability of mRNA\/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system","volume":"14","author":"Anderson","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mt.2014.180","article-title":"Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice","volume":"23","author":"Ayers","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0040","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI22922","article-title":"Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy","volume":"114","author":"Azzouz","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.copbio.2019.01.002","article-title":"Engineering the AAV capsid to evade immune responses","volume":"60","author":"Barnes","year":"2019","journal-title":"Curr. Opin. Biotechnol. Pharm. Biotechnol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0050","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182904faa","article-title":"Safety\/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients","volume":"80","author":"Bartus","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/mt.2013.281","article-title":"Parkinson\u2019s disease gene therapy: success by design meets failure by efficacy","volume":"22","author":"Bartus","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/mt.2012.261","article-title":"Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice","volume":"21","author":"Benkhelifa-Ziyyat","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12031-015-0695-2","article-title":"Multifactorial gene therapy enhancing the glutamate uptake system and reducing oxidative stress delays symptom onset and prolongs survival in the SOD1-G93A ALS mouse model","volume":"58","author":"Benkler","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jgm.1137","article-title":"Analysis of the intracellular barriers encountered by nonviral gene carriers in a model of spatially controlled delivery to neurons","volume":"10","author":"Bergen","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0075","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/mt.2011.157","article-title":"Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders","volume":"19","author":"Bevan","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0080","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.ymthe.2017.05.017","article-title":"A new AAV10-U7-mediated gene therapy prolongs survival and restores function in an ALS mouse model","volume":"25","author":"Biferi","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0085","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/296151","article-title":"The trojan horse liposome technology for nonviral gene transfer across the blood-brain barrier [WWW document]","author":"Boado","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185943","article-title":"Effects of AAV-mediated knockdown of nNOS and GPx-1 gene expression in rat hippocampus after traumatic brain injury","volume":"12","author":"Boone","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/bjp.2008.349","article-title":"Viral vectors: from virology to transgene expression: viral vectors: from virology to transgene expression","volume":"157","author":"Bouard","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0100","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1093\/hmg\/ddr110","article-title":"Genetic therapy for the nervous system","volume":"20","author":"Bowers","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0105","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tibtech.2015.09.008","article-title":"Surface-engineered viral vectors for selective and cell type-specific gene delivery","volume":"33","author":"Buchholz","year":"2015","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0110","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1039\/c3bm60123d","article-title":"Molecular weight and architectural dependence of well-defined star-shaped poly(lysine) as a gene delivery vector","volume":"1","author":"Byrne","year":"2013","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1172-6-10","article-title":"Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule","volume":"6","author":"Calvo","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jconrel.2009.11.004","article-title":"Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo","volume":"142","author":"Cardoso","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2010.03.007","article-title":"Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery","volume":"40","author":"Chen","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0130","doi-asserted-by":"crossref","first-page":"19850","DOI":"10.1021\/am505223t","article-title":"Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas","volume":"6","author":"Chen","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tins.2015.08.003","article-title":"The molecular constituents of the blood\u2013Brain barrier","volume":"38","author":"Chow","year":"2015","journal-title":"Trends Neurosci. Neuroimmunol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2013.08.045","article-title":"Optimization of Tet1 ligand density in HPMA-co-oligolysine copolymers for targeted neuronal gene delivery","volume":"34","author":"Chu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1566523054546224","article-title":"Altering the tropism of lentiviral vectors through pseudotyping","volume":"5","author":"Cronin","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0150","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/sj.gt.3302516","article-title":"Tf-lipoplex-mediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury","volume":"12","author":"da Cruz","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.polymer.2017.07.008","article-title":"Removal of retained electrospinning solvent prolongs drug release from electrospun PLLA fibers","volume":"123","author":"D\u2019Amato","year":"2017","journal-title":"Polymer"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-6-71","article-title":"Spinal muscular atrophy","volume":"6","author":"D\u2019Amico","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2019.01.019","article-title":"Luxturna: FDA documents reveal the value of a costly gene therapy","author":"Darrow","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/mtm.2013.5","article-title":"Targeted CNS delivery using human MiniPromoters and demonstrated compatibility with adeno-associated viral vectors","volume":"1","author":"de Leeuw","year":"2014","journal-title":"Mol. Ther. \u2013 Meth. Clin. Dev."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2013.03.009","article-title":"Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord","volume":"168","author":"Dengler","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2015.03.005","article-title":"Nanofiber-mediated microRNA delivery to enhance differentiation and maturation of oligodendroglial precursor cells","volume":"208","author":"Diao","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0185","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0190","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/mt.2011.249","article-title":"Efficient gene therapy for Parkinson\u2019s disease using astrocytes as hosts for localized neurotrophic factor delivery","volume":"20","author":"Drinkut","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0195","series-title":"Polymeric Biomaterials, Revised and Expanded","author":"Dumitriu","year":"2001"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.01.023","article-title":"Selective transduction of astrocytic and neuronal CNS subpopulations by lentiviral vectors pseudotyped with Chikungunya virus envelope","volume":"123","author":"Eleftheriadou","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0205","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/c2cs15327k","article-title":"Design of polymeric nanoparticles for biomedical delivery applications","volume":"41","author":"Elsabahy","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0210","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.nbd.2011.08.018","article-title":"Gene therapy for amyotrophic lateral sclerosis","volume":"48","author":"Federici","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2015.12.012","article-title":"Non-viral gene therapy: gains and challenges of non-invasive administration methods","volume":"240","author":"Foldvari","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches to transport therapeutic drugs across the blood\u2013brain barrier to treat brain diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis. Special Issue: Blood Brain Barrier"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0230","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.celrep.2013.12.013","article-title":"RNAi factors are present and active in human cell nuclei","volume":"6","author":"Gagnon","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hgtb.2017.098","article-title":"Manufacture of third-generation lentivirus for preclinical use, with process development considerations for translation to good manufacturing practice","volume":"29","author":"G\u00e1ndara","year":"2018","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0240","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1016\/j.biomaterials.2013.03.097","article-title":"Glioma targeting and blood\u2013brain barrier penetration by dual-targeting doxorubincin liposomes","volume":"34","author":"Gao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0245","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jconrel.2016.10.027","article-title":"A non-viral suicide gene delivery system traversing the blood brain barrier for non-invasive glioma targeting treatment","volume":"243","author":"Gao","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0250","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/bm401906p","article-title":"RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain","volume":"15","author":"Gao","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0255","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nm1297-1402","article-title":"Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin","volume":"3","author":"Geddes","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0260","series-title":"ClinicalTrials.gov","author":"Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1 - ClinicalTrials.gov [WWW Document]","year":"2017"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jgm.2698","article-title":"Gene therapy clinical trials worldwide to 2012 \u2013 an update","volume":"15","author":"Ginn","year":"2013","journal-title":"J. Gene Med."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0270","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1002\/jgm.3015","article-title":"Gene therapy clinical trials worldwide to 2017: an update","volume":"20","author":"Ginn","year":"2018","journal-title":"J. Gene Med."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0275","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2011.11.121","article-title":"Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of Spinal Muscular Atrophy","volume":"417","author":"Glascock","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0280","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.biomaterials.2013.09.068","article-title":"Differential nanotoxicological and neuroinflammatory liabilities of non-viral vectors for RNA interference in the central nervous system","volume":"35","author":"Godinho","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0285","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ymthe.2006.09.001","article-title":"Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats","volume":"14","author":"Gonzalez-Barrios","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0290","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.gt.3300635","article-title":"Size, diffusibility and transfection performance of linear PEI\/DNA complexes in the mouse central nervous system","volume":"5","author":"Goula","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0295","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/wound.2011.0325","article-title":"Biomaterial Scaffolds for controlled, localized gene delivery of regenerative factors","volume":"2","author":"Gower","year":"2013","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0300","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0305","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0310","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0315","article-title":"Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury","volume":"1","author":"Griffin","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0320","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s13346-017-0368-5","article-title":"Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes","volume":"7","author":"Gu","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0325","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1002\/jbm.a.35489","article-title":"Multifunctional nanoparticles for gene delivery and spinal cord injury","volume":"103","author":"Gwak","year":"2015","journal-title":"J. Biomed. Mater. Res. A."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0330","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/app.33995","article-title":"Construction of novel brain-targeting gene delivery system by natural magnetic nanoparticles","volume":"121","author":"Han","year":"2011","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0335","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12929-015-0166-7","article-title":"Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson\u2019s disease","volume":"22","author":"Hernandez-Chan","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/hum.2017.026","article-title":"Evaluation of intrathecal routes of administration for adeno-associated viral vectors in large animals","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe toxicity in nonhuman Primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0350","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.brainresbull.2009.12.008","article-title":"Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo","volume":"81","author":"Huang","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0355","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/jcbfm.2009.104","article-title":"Brain-targeting mechanisms of lactoferrin-modified DNA-Loaded nanoparticles","volume":"29","author":"Huang","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0360","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biomaterials.2007.09.024","article-title":"The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0365","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2009.09.032","article-title":"Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model","volume":"290","author":"Huang","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0370","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s11095-013-1005-8","article-title":"Angiopep-conjugated nanoparticles for targeted long-term gene therapy of Parkinson\u2019s disease","volume":"30","author":"Huang","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0375","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1096\/fj.06-7380com","article-title":"Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer","volume":"21","author":"Huang","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0380","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1016\/j.biomaterials.2011.05.006","article-title":"Robust CNS regeneration after complete spinal cord transection using aligned poly-l-lactic acid microfibers","volume":"32","author":"Hurtado","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0385","series-title":"ClinicalTrials.gov","author":"Intratumoral\/Intralesional Administration of MK-4621\/JetPEITM With or Without Pembrolizumab in Participants With Advanced\/Metastatic or Recurrent Solid Tumors (MK-4621-002) - ClinicalTrials.gov [WWW Document]","year":"2018"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0390","first-page":"116","article-title":"Better targeting, better efficiency for wide-scale neuronal transduction with the synapsin promoter and AAV-PHP.B","volume":"9","author":"Jackson","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0395","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1080\/17425247.2016.1188802","article-title":"Current status of non-viral gene therapy for CNS disorders","volume":"13","author":"Jayant","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0400","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1113\/JP270874","article-title":"The repair Schwann cell and its function in regenerating nerves","volume":"594","author":"Jessen","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0405","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s11095-010-0320-6","article-title":"Bioactive electrospun Scaffolds delivering growth factors and genes for tissue engineering applications","volume":"28","author":"Ji","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0410","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1038\/s41598-017-11220-1","article-title":"Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma","volume":"7","author":"Johnsen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0415","doi-asserted-by":"crossref","first-page":"e01394","DOI":"10.1128\/JVI.01394-18","article-title":"High-resolution structural characterization of a new adeno-associated virus serotype 5 antibody epitope toward engineering antibody-resistant recombinant gene delivery vectors","volume":"93","author":"Jose","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0420","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.omtn.2018.06.009","article-title":"Reaching for the stars in the brain: polymer-mediated gene delivery to human astrocytes","volume":"12","author":"Joshi","year":"2018","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0425","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1016\/j.biomaterials.2013.08.036","article-title":"Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles","volume":"34","author":"Kanazawa","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0430","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1002\/adma.201600634","article-title":"Self-sealing porous silicon-calcium silicate core\u2013shell nanoparticles for targeted siRNA delivery to the injured brain","volume":"28","author":"Kang","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0435","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1523\/JNEUROSCI.0183-10.2010","article-title":"Transfection techniques for neuronal cells","volume":"30","author":"Karra","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0440","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/83324","article-title":"Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics","volume":"7","author":"Kay","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0445","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1016\/j.biomaterials.2009.08.049","article-title":"Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer","volume":"30","author":"Ke","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0450","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1007\/s00216-010-3821-6","article-title":"Mammalian cell transfection: the present and the future","volume":"397","author":"Kim","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0455","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejpb.2007.02.025","article-title":"Thermoresponsive hydrogels in biomedical applications","volume":"68","author":"Klouda","year":"2008","journal-title":"Eur. J. Pharm. Biopharm. Interact. Polym. Pharmaceut. Biomed. Appl."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0460","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1432-1327.1999.00108.x","article-title":"Non-viral neuronal gene delivery mediated by the HC fragment of tetanus toxin","volume":"259","author":"Knight","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0465","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jconrel.2008.10.013","article-title":"Liposome encapsulated polyethylenimine\/ODN polyplexes for brain targeting","volume":"133","author":"Ko","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0470","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1073\/pnas.1308345110","article-title":"Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium","volume":"110","author":"Kolhar","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0475","doi-asserted-by":"crossref","first-page":"609","DOI":"10.15252\/emmm.201506078","article-title":"A brain microvasculature endothelial cell\u2010specific viral vector with the potential to treat neurovascular and neurological diseases","volume":"8","author":"K\u00f6rbelin","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0480","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0485","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1021\/acsnano.6b03858","article-title":"Neuron-targeted nanoparticle for siRNA delivery to traumatic brain injuries","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0490","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA versus miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0495","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1754-1611-8-30","article-title":"Electrospun nanofibers as versatile interfaces for efficient gene delivery","volume":"8","author":"Lee","year":"2014","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0500","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1016\/j.biomaterials.2013.08.030","article-title":"Choline transporter-targeting and co-delivery system for glioma therapy","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0505","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/rb\/rbw007","article-title":"Recent advances of biomaterials in biotherapy","volume":"3","author":"Li","year":"2016","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0510","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/bm401558c","article-title":"Nanofibers support oligodendrocyte precursor cell growth and function as a neuron-free model for myelination study","volume":"15","author":"Li","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0515","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1039\/C1CS15203C","article-title":"Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications","volume":"41","author":"Li","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0520","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.gt.3302135","article-title":"CNS gene transfer mediated by a novel controlled release system based on DNA complexes of degradable polycation PPE-EA: a comparison with polyethylenimine\/DNA complexes","volume":"11","author":"Li","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0525","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1023\/A:1023887203111","article-title":"Controlled gene delivery system based on thermosensitive biodegradable hydrogel","volume":"20","author":"Li","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0530","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.molmet.2015.03.003","article-title":"Brain-derived neurotrophic factor is required for axonal growth of selective groups of neurons in the arcuate nucleus","volume":"4","author":"Liao","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0535","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2009.06.007","article-title":"Sustained viral gene delivery through core-shell fibers","volume":"139","author":"Liao","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0540","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2005.01.022","article-title":"A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting","volume":"19","author":"Liu","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0545","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.actbio.2017.07.024","article-title":"Regulated viral BDNF delivery in combination with Schwann cells promotes axonal regeneration through capillary alginate hydrogels after spinal cord injury","volume":"60","author":"Liu","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0550","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biomaterials.2015.11.060","article-title":"Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer\u2019s disease mice","volume":"80","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0555","article-title":"Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of parkinson\u2019s disease","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0560","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0565","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1016\/j.biomaterials.2010.03.011","article-title":"A leptin derived 30-amino-acid peptide modified pegylated poly-l-lysine dendrigraft for brain targeted gene delivery","volume":"31","author":"Liu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0570","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10611860400015936","article-title":"Nanoparticle surface charges alter blood\u2013brain barrier integrity and permeability","volume":"12","author":"Lockman","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0575","article-title":"Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0580","doi-asserted-by":"crossref","DOI":"10.1038\/nbt0607-631","article-title":"MicroRNA gets down to business [WWW Document]","author":"Mack","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0585","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0971-6866.112870","article-title":"Delivery systems for gene therapy","volume":"19","author":"Mali","year":"2013","journal-title":"Indian J. Hum. Genet."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0590","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2014.210","article-title":"Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose\u2013response study in mice and nonhuman primates","volume":"23","author":"Meyer","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0595","first-page":"3637","article-title":"Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy","volume":"7","author":"Miele","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0600","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0605","doi-asserted-by":"crossref","first-page":"12349","DOI":"10.1073\/pnas.93.22.12349","article-title":"Evidence for the role of proteoglycans in cation-mediated gene transfer","volume":"93","author":"Mislick","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0610","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-5793(89)80926-3","article-title":"Light chain of tetanus toxin intracellularly inhibits acetylcholine release at neuro-neuronal synapses, and its internalization is mediated by heavy chain","volume":"253","author":"Mochida","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0615","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-biochem-060408-092949","article-title":"Genomic screening with RNAi: results and challenges","volume":"79","author":"Mohr","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0620","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00109-009-0556-y","article-title":"Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy","volume":"88","author":"Moreno-Igoa","year":"2010","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0625","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the \u03b2-amyloid peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0630","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0635","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.celrep.2017.03.048","article-title":"Rapid molecular profiling of defined cell types using viral TRAP","volume":"19","author":"Nectow","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0640","article-title":"Three-dimensional aligned nanofibers-hydrogel scaffold for controlled non-viral drug\/gene delivery to direct axon regeneration in spinal cord injury treatment","volume":"7","author":"Nguyen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0645","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2016.00076","article-title":"Neuroprotective effect of non-viral gene therapy treatment based on tetanus toxin C-fragment in a severe mouse model of spinal muscular atrophy","volume":"9","author":"Oliv\u00e1n","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0650","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2013.11.001","article-title":"Polymeric nanoparticle system to target activated microglia\/macrophages in spinal cord injury","volume":"174","author":"Papa","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0655","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.copbio.2018.03.001","article-title":"Genome engineering for CNS injury and disease","volume":"52","author":"Pardieck","year":"2018","journal-title":"Curr. Opin. Biotechnol. Tissue, Cell Pathway Eng."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0660","doi-asserted-by":"crossref","DOI":"10.1177\/1756285618754501","article-title":"Advances in spinal muscular atrophy therapeutics","volume":"11","author":"Parente","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0665","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jgm.1062","article-title":"Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine)","volume":"9","author":"Park","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0670","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biomaterials.2014.10.068","article-title":"Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer\u2019s disease","volume":"38","author":"Park","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0675","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.addr.2006.03.007","article-title":"Current status of polymeric gene delivery systems","volume":"58","author":"Park","year":"2006","journal-title":"Adv. Drug Deliv. Rev. Gene Deliv. Tissue Eng."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0680","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"Passini","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0685","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.actbio.2018.05.054","article-title":"Sustained delivery of siRNA\/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing","volume":"76","author":"Pinese","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0690","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.biomaterials.2013.11.039","article-title":"Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma","volume":"35","author":"Qian","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0695","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2952386","article-title":"The extracellular environment of the CNS: influence on plasticity, sprouting, and axonal regeneration after spinal cord injury [WWW document]","author":"Quraishe","year":"2018","journal-title":"Neural Plast."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0700","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jalz.2013.09.004","article-title":"A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer\u2019s disease","volume":"10","author":"Rafii","year":"2014","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0705","series-title":"Integrated Biomaterials for Biomedical Technology","author":"Ramalingam","year":"2012"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0710","first-page":"GE01","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0715","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1083\/jcb.34.1.207","article-title":"Fine structural localization of a blood-brain barrier to exogenous peroxidase","volume":"34","author":"Reese","year":"1967","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0720","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2013.03.010","article-title":"Improved axonal regeneration after spinal cord injury in mice with conditional deletion of ephrin B2 under the GFAP promoter","volume":"241","author":"Ren","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0725","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt936","article-title":"Rational siRNA design for RNA interference","volume":"22","author":"Reynolds","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0730","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.gt.3302766","article-title":"Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice","volume":"13","author":"Rivi\u00e8re","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0735","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11095-018-2554-7","article-title":"Pharmaceutical development of AAV-based gene therapy products for the eye","volume":"36","author":"Rodrigues","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0740","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2011.08.026","article-title":"Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery","volume":"157","author":"Rogers","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0745","doi-asserted-by":"crossref","first-page":"16026","DOI":"10.1038\/mtm.2016.26","article-title":"Microglia-specific targeting by novel capsid-modified AAV6 vectors","volume":"3","author":"Rosario","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0750","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2011.08.023","article-title":"Viral-mediated overexpression of mutant huntingtin to model HD in various species","volume":"48","author":"Ruiz","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0755","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2016.06.005","article-title":"MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson\u2019s disease","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0760","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7378.1","article-title":"The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?","volume":"5","author":"Saunders","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0765","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.bioeng.10.061807.160514","article-title":"Molecular engineering of viral gene delivery vehicles","volume":"10","author":"Schaffer","year":"2008","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0770","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.addr.2006.09.020","article-title":"Thermo- and pH-responsive polymers in drug delivery\u22c6","volume":"58","author":"Schmaljohann","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0775","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/mt.2009.41","article-title":"Biological gene delivery vehicles: beyond viral vectors","volume":"17","author":"Seow","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0780","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejps.2014.09.021","article-title":"Development and characterization of a cationic lipid nanocarrier as non-viral vector for gene therapy","volume":"66","author":"Severino","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2013.01.016","article-title":"Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: biodistribution and transfection","volume":"167","author":"Sharma","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0790","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.actbio.2016.12.048","article-title":"Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson\u2019s Disease (PD)","volume":"54","author":"Sheikh","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0795","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/bit.24355","article-title":"Hydrogel design for supporting neurite outgrowth and promoting gene delivery to maximize neurite extension","volume":"109","author":"Shepard","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0800","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1038\/mtna.2015.15","article-title":"Intraventricular delivery of siRNA nanoparticles to the central nervous system","volume":"4","author":"Shyam","year":"2015","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0805","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2014.06.006","article-title":"Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain","volume":"188","author":"Somani","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0810","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.biomaterials.2009.09.085","article-title":"Gene transfer using self-assembled ternary complexes of cationic magnetic nanoparticles, plasmid DNA and cell-penetrating Tat peptide","volume":"31","author":"Song","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0815","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/smll.200901513","article-title":"Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery","volume":"6","author":"Song","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0820","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.biomaterials.2011.10.035","article-title":"Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome","volume":"33","author":"Sun","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0825","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number, and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0830","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/mthe.2000.0224","article-title":"Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain","volume":"3","author":"Thomas","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0835","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0840","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00253-003-1321-8","article-title":"Non-viral gene therapy: polycation-mediated DNA delivery","volume":"62","author":"Thomas","year":"2003","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0845","series-title":"Encyclopedia of Clinical Neuropsychology","article-title":"Blood-brain barrier","author":"Tran","year":"2011"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0850","series-title":"ClinicalTrials.gov","author":"TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer - ClinicalTrials.gov [WWW Document]","year":"2011"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0855","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2008.08.021","article-title":"Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood\u2013brain barrier (BBB)","volume":"71","author":"Ulbrich","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0860","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy","volume":"2","author":"Valori","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0865","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1093\/hmg\/ddv451","article-title":"Progress and challenges in viral vector manufacturing","volume":"25","author":"van der Loo","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0870","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrg2141","article-title":"Engineering targeted viral vectors for gene therapy","volume":"8","author":"Waehler","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0875","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1016\/j.biomaterials.2010.04.057","article-title":"PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrier","volume":"31","author":"Wang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0880","doi-asserted-by":"crossref","DOI":"10.1088\/1741-2560\/6\/1\/016001","article-title":"Creation of highly aligned electrospun poly-L-lactic acid fibers for nerve regeneration applications","volume":"6","author":"Wang","year":"2009","journal-title":"J. Neural Eng."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0885","doi-asserted-by":"crossref","DOI":"10.3390\/nano6010003","article-title":"Receptor-mediated drug delivery systems targeting to Glioma","volume":"6","author":"Wang","year":"2015","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0890","first-page":"82","article-title":"Adeno-associated virus (AAV) gene therapy for neurological disease","volume":"69","author":"Weinberg","year":"2013","journal-title":"Neuropharmacol. New Targets Approach. Treat. Epilepsy"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0895","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gene.2013.03.137","article-title":"History of gene therapy. Gene, 50 years of gene therapy - a contribution of Waclaw Szybalski to science and humanity","volume":"525","author":"Wirth","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0900","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jconrel.2012.07.002","article-title":"Lipid peptide nanocomplexes for gene delivery and magnetic resonance imaging in the brain","volume":"162","author":"Writer","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0905","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.actbio.2018.03.030","article-title":"RGD\/TAT-functionalized chitosan-graft-PEI-PEG gene nanovector for sustained delivery of NT-3 for potential application in neural regeneration","volume":"72","author":"Wu","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0910","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jocn.2011.12.023","article-title":"Wnt inhibitory factor-1 regulates glioblastoma cell cycle and proliferation","volume":"19","author":"Wu","year":"2012","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0915","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.drudis.2017.04.001","article-title":"Recent development of synthetic nonviral systems for sustained gene delivery","volume":"22","author":"Xiang","year":"2017","journal-title":"Drug Discov. Today, SI: Therapeutic Nanomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0920","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.actbio.2011.02.031","article-title":"Core\u2013sheath structured fibers with pDNA polyplex loadings for the optimal release profile and transfection efficiency as potential tissue engineering scaffolds","volume":"7","author":"Yang","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0925","doi-asserted-by":"crossref","first-page":"21402","DOI":"10.1038\/srep21402","article-title":"A novel gene delivery composite system based on biodegradable folate-poly (ester amine) polymer and thermosensitive hydrogel for sustained gene release","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0930","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biomaterials.2014.10.034","article-title":"Enhanced blood\u2013brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system","volume":"37","author":"Yao","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0935","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.biomaterials.2006.11.015","article-title":"Self-assembled ternary complexes of plasmid DNA, low molecular weight polyethylenimine and targeting peptide for nonviral gene delivery into neurons","volume":"28","author":"Zeng","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0940","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1128\/JVI.01375-12","article-title":"Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesis","volume":"87","author":"Zerboni","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/10430340360464660","article-title":"Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental Parkinsonism","volume":"14","author":"Zhang","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0950","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1158\/1078-0432.CCR-03-0740","article-title":"Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer","volume":"10","author":"Zhang","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0955","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.actbio.2016.03.048","article-title":"Conjugates of small targeting molecules to non-viral vectors for the mediation of siRNA","volume":"36","author":"Zhi","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.brainresbull.2019.05.024_bib0960","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.devcel.2015.06.011","article-title":"CNS myelin wrapping is driven by actin disassembly","volume":"34","author":"Zuchero","year":"2015","journal-title":"Dev. Cell"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923018310086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923018310086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:37:54Z","timestamp":1759783074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923018310086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":192,"alternative-id":["S0361923018310086"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2019.05.024","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2019.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}